copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
BIOTEST We would like to show you a description here but the site won’t allow us
Company Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine Biotest develops, manufactures and markets plasma proteins and biotherapeutic drugs Our value chain extends from pre-clinical and clinical development to worldwide marketing and distribution
Biotest AG Biotest ist ein weltweit tätiger Anbieter von Plasmaproteinprodukten und biotherapeutischen Arzneimitteln Die Produkte von Biotest kommen vorrangig in den Anwendungsgebieten klinische Immunologie, Hämatologie und Intensivmedizin zum Einsatz
Grifols successfully completes Biotest delisting Grifols (MCE: GRF, MCE: GRF P NASDAQ: GRFS), a global healthcare company and leading producer of plasma-derived medicines, today announced it has successfully completed the delisting of its German subsidiary Biotest AG, after increasing its stake in Biotest’s share capital to 80 32%
Biotest Biotest is a global company that supplies plasma protein products and biotherapeutic drugs Our products are primarily used in the therapeutic areas of clinical immunology, haematology and intensive care medicine
Grifols announces its investment in Biotest Biotest is a German public listed healthcare company specialized in innovative hematology and clinical immunology with an attractive pipeline with novel proteins that complement Grifols’ product portfolio
Biotest Press releases Biotest is a global company that supplies plasma protein products and biotherapeutic drugs Our products are primarily used in the therapeutic areas of clinical immunology, haematology and intensive care medicine